Solara Active Pharma Sciences Ltd share price logo

Solara Active Pharma Sciences Ltd

NSE: SOLARA

BSE: 541540

Small Cap

Pharma Sector

₹636.70

+2.15

(+0.34%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Solara Active Pharma Sciences shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Average holding period of indmoney investors

6 days

INDmoney investors hold Solara Active Pharma Sciences shares for an average of 6 days.

Key Events for Solara Active Pharma Sciences

Last Dividend Declared

₹3.00 per share, declared on 06/05/2021

View Dividend History

Solara Active Pharma Sciences Stock Performance

as on October 27, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹628.05
    ₹657.45
    downward going graph

    1.36%

    Downside

    3.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹422.00
    ₹774.00
    downward going graph

    33.72%

    Downside

    21.56%

    Upside

    downward going graph

Solara Active Pharma Sciences share price movements today

Previous Close
₹634.55
Open
₹635.10
Volume
3.15L
Upper Circuit
₹761.45
Lower Circuit
₹507.65
Day's Low - High
₹628.05 - ₹657.45
52 Week Low - High
₹422.00 - ₹774.00

Solara Active Pharma Sciences Historical Returns

1 Month Return
-13.82 %
3 Month Return
+ 25.65 %
1 Year Return
+ 7.38 %
3 Year Return
+ 105.32 %
5 Year Return
-50.19 %

Solara Active Pharma Sciences Fundamentals

as on October 27, 2026 at 4:01 pm IST

Market Cap

₹3,079.61 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

82.84

Return on capital employed (ROCE)

0

Industry PE ratio

48.9

Beta (LTM)

0.82

P/B Ratio

1.51

Dividend Yield

0

PEG Ratio

12.82

Quarterly Earnings Growth YOY

-381.78

EPS (TTM)

-1.66

Book Value

281.48

Solara Active Pharma Sciences Stock Valuation

as on October 27, 2026 at 4:01 pm IST

Solara Active Pharma Sciences in the last 5 years

  • Overview

  • Trends

Lowest (-1214.92x)

September 21, 2026

Industry (48.90x)

October 26, 2026

Today (82.84x)

October 26, 2026

Highest (4538.57x)

June 25, 2025

LowHigh

Today’s Price to Earnings Ratio: 82.84x

Solara Active Pharma Sciences Technical Analysis

Track how Solara Active Pharma Sciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish1
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.58
Bearish
CCI (20)
120.19
Bearish
RSI (14)
41.18
Neutral
Momentum (10)
-2.55
Bullish
ADI (14)
25.04
Bearish
Ultimate Oscillator (7,14,28)
31.44
Neutral

Moving Averages

Name

Value

Action

SMA (20)
637.38
Bearish
EMA (20)
636.86
Bearish
VWMA (20)
636.87
Bearish
SMA (50)
637.38
Bearish
EMA (50)
637.34
Bearish
SMA (200)
643.66
Bearish
EMA (200)
640.92
Bearish
KAMA (200)
636.67
Bearish
DEMA (200)
638.63
Bearish

Solara Active Pharma Sciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Solara Active Pharma Sciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Solara Active Pharma Sciences Ltd image
Solara Active Pharma Sciences Ltd
NA3,079.61-10.04%0.69-81,368
Astonea Labs Ltd image
Astonea Labs Ltd
NA339.5127.62%0.724147
Shelter Pharma Ltd image
Shelter Pharma Ltd
NA72.840.62%0.00973
Decipher Labs Ltd image
Decipher Labs Ltd
NA5.25-16.44%0.51-414
Gufic BioSciences Ltd image
Gufic BioSciences Ltd
NA4,085.0120.96%0.7064944
See all

Solara Active Pharma Sciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
211.94
299.43
363.49
346.95
300.31
273.01
319.15
313.54
349
387.29
381.6
417.34
Other Income
0.45
1.7
0.56
0.32
1.49
5.95
0.98
0.49
-
5.55
2.69
0.54
Total Income
212.39
301.13
364.05
347.27
301.8
278.96
320.13
314.03
349
392.84
384.29
417.88
Expenses
436.4
411.85
321.57
285.64
242.63
227.64
262.13
278.81
318.41
329.63
319.63
345
Operating Profit
-224.46
-112.42
41.92
61.31
57.68
45.37
57.02
34.73
30.59
57.66
61.97
72.34
Operating Profit Margin %
-105.91%
-37.54%
11.53%
17.67%
19.21%
16.62%
17.87%
11.08%
8.77%
14.89%
16.24%
17.33%
Profit Before Interest, Tax and Depreciation
-224.01
-110.72
42.48
61.63
59.17
51.32
58
35.22
30.59
63.21
64.66
72.88
Interest
25.37
30.69
30.87
28.28
26.54
29.12
23.9
20.83
22.45
27.57
21.64
17.78
Depreciation
25.96
25.25
25.07
25.34
24.54
24.3
23.58
24.49
25.57
26.04
26.71
26.64
Profit Before Tax
-275.34
-166.66
-13.46
8.01
8.09
-2.1
10.52
-10.1
-17.43
9.6
16.31
28.46
Tax Paid
-
88.79
-
-
-
-
-
-
-
-
-
-
Profit After Tax
-275.34
-255.45
-13.46
8.01
8.09
-2.1
10.52
-10.1
-17.43
9.6
16.31
28.46
Total Net profit including share of profit / Loss from associate company
-275.34
-255.45
-13.46
8.01
8.09
-2.1
10.52
-10.1
-17.43
9.6
16.31
28.46
EPS
-72.07
-70.93
-3.5
2.54
2.03
-0.93
2.46
-2.36
-3.98
2.2
3.52
5.92
Actual EPS
-72.07
-70.93
-3.5
2.54
2.03
-0.93
2.46
-2.36
-3.98
2.2
3.52
5.92
Adjusted EPS
-66.42
-65.37
-3.5
2.54
2.03
-0.93
2.46
-2.36
-3.98
2.2
3.52
5.92
Diluted EPS
-72.07
-70.93
-3.5
2.54
2.03
-0.93
2.46
-2.36
-3.98
2.2
3.52
5.92

Solara Active Pharma Sciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
520.97
1,386.68
1,321.75
1,616.88
1,268.34
1,443.81
1,288.92
1,283.76
1,368.98
Other Income
2.45
12.38
27.52
28.77
20.02
22.55
5.37
8.32
6.16
Total Income
523.42
1,399.06
1,349.27
1,645.65
1,288.36
1,466.36
1,294.29
1,292.08
1,375.14
Expenses
464.1
1,173.56
1,062.31
1,231.01
1,191.86
1,309.92
1,574.27
1,077.48
1,188.12
Operating Profit
56.87
213.12
259.44
385.87
76.48
133.89
-285.35
206.28
180.86
Operating Profit Margin %
10.92%
15.37%
19.63%
23.87%
6.03%
9.27%
-22.14%
16.07%
13.21%
Profit Before Interest, Tax and Depreciation
59.32
225.5
286.96
414.64
96.5
156.44
-279.98
214.6
187.02
Interest
25.14
82.42
77.89
84.48
75.28
90.06
105.11
114.81
94.75
Depreciation
33.98
83.09
94.16
108.66
112.32
111.19
103.33
99.25
99.68
Profit Before Tax
0.2
59.99
114.91
221.5
-91.1
-44.81
-488.42
0.54
-7.41
Tax Paid
-0.14
0.58
0.39
0.15
-32.81
-22.57
78.54
-
-
Profit After Tax
0.34
59.41
114.52
221.35
-58.29
-22.24
-566.96
0.54
-7.41
Total Net profit including share of profit / Loss from associate company
0.34
59.41
114.52
221.35
-58.29
-22.24
-566.96
0.54
-7.41
EPS
0.34
21.76
44.29
69
-16.18
-6.16
-157.62
0.14
-1.68
Actual EPS
0.34
21.76
44.29
69
-16.18
-6.16
-157.62
0.14
-1.68
Adjusted EPS
0.31
20.05
40.82
63.59
-14.91
-5.68
-145.27
0.14
-1.68
Diluted EPS
0.34
21.72
42.82
64.52
-16.18
-6.16
-157.62
0.14
-1.68

Solara Active Pharma Sciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
49.22
166.33
242.15
155.46
-242.03
156.25
108.87
212.82
152.91
Cash Flow from Investing Activities
-85.47
-54.17
-89.94
68.18
-34.23
30.17
37.55
3.11
-46.01
Cash Flow from Financing Activities
67.74
-23.39
96.98
92.49
333.57
-112.76
-105.65
-180.48
-53.55
Net Cash Flow
31.49
29.77
-19.68
141.65
-151.31
-37.65
-0.29
-4.49
0.53

Solara Active Pharma Sciences Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
May 2026
Jun 2026
Sep 2026
Promoters
30.49%
30.49%
37.27%
37.27%
37.23%
37.94%
42.01%
42.01%
42%
42%
42%
41.93%
41.93%
DII
1.71%
2.97%
2.83%
3.38%
3.19%
2.61%
2.62%
2.69%
3.64%
3.75%
3.78%
3.74%
3.89%
FII
0%
15.8%
14%
14.25%
14.67%
14.63%
14.25%
13.58%
11.98%
11.59%
11.33%
11.52%
10.71%
Public
51.14%
50.74%
45.9%
45.1%
44.91%
44.81%
41.11%
41.72%
42.37%
42.66%
42.89%
42.81%
43.46%
Total Outstanding Shares
3,59,96,267
3,59,96,267
4,80,04,022
4,80,04,022
4,80,53,022
4,80,53,022
4,81,53,022
4,81,53,022
4,81,71,562
4,81,71,562
4,81,73,762
4,82,46,012
4,82,50,512
Total Shareholders
72,918
73,912
77,170
71,882
83,148
75,791
74,334
72,479
71,920
70,400
70,037
70,490
70,905

Mutual Funds Buying / Exiting Solara Active Pharma Sciences

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Solara Active Pharma Sciences

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Motilal Oswal BSE 1000 Index Fund Direct Growth

Motilal Oswal BSE 1000 Index Fund Direct Growth

₹0.00 Cr

₹0.00 Cr (+4.56%)

0.01%

Mutual Funds Exiting Solara Active Pharma Sciences

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.02 Cr

₹0.00 Cr (-9.34%)

0.11%

Indices Featuring Solara Active Pharma Sciences Stock

Check stock indices that include Solara Active Pharma Sciences.

BSE Healthcare

₹48,909.83

+1,088.40 (▲2.28%)

Insights on Solara Active Pharma Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 42.81% to 43.46% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, SOLARA stock has moved up by 25.7%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -17.43 Cr → 28.46 Cr (in ₹), with an average increase of 121.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 384.29 Cr → 417.88 Cr (in ₹), with an average increase of 8.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Divis Laboratories Ltd has given 165.2% return, outperforming this stock by 59.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 41.93% of holdings in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 39.5% return, outperforming this stock by 32.1%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 0.95% to 0.87% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 11.52% to 10.71% in Sep 2026 quarter

About Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Ltd is a Public Limited Company incorporated in 2017 with operations in 75 countries across the globe, primarily dealing in APIs and developing 80 commercial APIs predominantly in anthelmintic antimalarias antiinfective neuromuscular insomnia and antipsychotic hyperkalemia segments. The business is spread across North America, Europe, Japan, South Korea, Middle East and North Africa offering a basket of niche and high-value products. The Company has six manufacturing plants in Ambernath, Mangalore, Mysore, Puducherry, Vishakhapatnam and Cuddalore, with a capacity of over 2000 kilo litres and two RD Centres in Chennai and Bangalore. The facilities boast of approvals from USFDA, EDQM, KFDA, EUGMP, WHO Geneva, Cofepris, TGA Australia, and PMDA Japan. In the financial year of 2020-21, the Company achieved a Certificate of Merit from National Safety Council Maharashtra and improved EcoVadis score from 31 to 47, awarded with a bronze medal and also achieved certification for ISO 14001 and ISO 45001 in its Mangalore site. The Company also has two research and development units with 25 products in different stages of development. The Board of Directors approved the Scheme of Amalgamation of Strides Chemicals and three other Transferor Companies with the Company Transferee Company, approved the acquisition of 487000 additional share capital in Sequent Penems Private Limited, and the new Greenfield plant has commenced commercial production in 2021.

Revenue: ₹417.34Cr as on September 2026 (Q2 FY27)
Net Profit: ₹28.46Cr as on September 2026 (Q2 FY27)
Listing date: 27 Jun, 2018
Chairperson Name: Aditya Puri
OrganisationSolara Active Pharma Sciences Ltd
HeadquartersChennai
IndustryPharmaceuticals
CEOAditya Puri
E-voting on sharesClick here to vote

FAQs

What is Solara Active Pharma Sciences share price today?

Solara Active Pharma Sciences share price today stands at ₹636.7 as on at the close of the market. Solara Active Pharma Sciences share today touched a day high of ₹657.45 and a low of ₹628.05.

What is the 52 week high and 52 week low range for Solara Active Pharma Sciences share?

Solara Active Pharma Sciences touched a 52 week high of ₹774 and a 52 week low of ₹422. Solara Active Pharma Sciences share price today i.e. is closed at ₹636.7, which is -17.74% down from its 52 week high and 50.88% up from its 52 week low.

What is Solara Active Pharma Sciences's market capitalisation today?

Solara Active Pharma Sciences market capitalisation is ₹3,079.61 Cr as on .

How to buy Solara Active Pharma Sciences shares?

To buy Solara Active Pharma Sciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SOLARA or Solara Active Pharma Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Solara Active Pharma Sciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Solara Active Pharma Sciences trading volume today?

Solara Active Pharma Sciences trading volume is 3.15L as on . This means that 3.15L shares of Solara Active Pharma Sciences were bought and sold on the stock market during today's trading session.